CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma (OS) is a highly malignant bone tumor with poor early diagnostic markers.
• The underlying pathogenesis of OS requires further elucidation for improved patient management.
• Circular RNAs (circRNAs) are stable non-coding RNAs involved in various cellular processes, including cancer progression.

Purpose of the Study:

• To investigate the role of circRNA-CIRH1A in osteosarcoma (OS).
• To identify potential diagnostic biomarkers and therapeutic targets for OS.

Main Methods:

• Upregulation of circRNA-CIRH1A in OS tissues and cell lines was assessed.
• Functional studies involved silencing circRNA-CIRH1A in OS cell lines and a xenograft mouse model.
• Mechanistic investigations explored the interaction between circRNA-CIRH1A and miR-1276, and its impact on PI3K/AKT and JAK2/STAT3 signaling pathways.

Main Results:

• CircRNA-CIRH1A was found to be upregulated in OS tissues and cell lines.
• Silencing circRNA-CIRH1A inhibited OS cell proliferation, invasion, migration, and apoptosis in vitro and in vivo.
• CircRNA-CIRH1A was shown to sponge miR-1276, thereby affecting the PI3K/AKT and JAK2/STAT3 signaling pathways.

Conclusions:

• CircRNA-CIRH1A plays an oncogenic role in osteosarcoma progression.
• The miR-1276/PI3K-AKT and JAK2-STAT3 signaling axis represents a key downstream mediator of circRNA-CIRH1A's function in OS.
• CircRNA-CIRH1A is a potential therapeutic target for osteosarcoma.